A clinical trial comparing methotrexate and the more expensive mycophenolate mofetil treating non-infectious uveitis shows the two drugs offer very similar...

Researchers from École Polytechnique Fédérale de Lausanne in Switzerland and Scuola Superiore Sant’Anna in Italy have developed a new type of intraneural...

A retrospective review found low-level light therapy (LLLT) successfully resolved recalcitrant chalazia in most patients who failed topical or systemic...

Researchers at SUNY Downstate Health Sciences University in Brooklyn are working on a science fiction-esque optogenetic technology to give blind people...

A new organisation to promote the development and knowledge of scleral lenses, the Euro and Austral-Asian Scleral Lens Academy (EASLA), has been created...

Digital security is under the microscope, with the Ministry of Health encouraging health organisations to ensure the digital services they use are safe and...

VSP’s airy, bright and large central O=Mega19 stand was designed as an open booth to encourage visitors to move through to view as many of the latest designs...

Last year’s Dry Eye Assessment and Management (DREAM) Research Group study finding that omega-3 supplements were no better than an olive oil placebo for...

Consultations launched on 11 September by the Australian Health Practitioner Regulation Agency (AHPRA) ask people to have their say on revised guidance...

Acknowledging the issue of surgery potentially exacerbating or inducing ocular surface disease (OSD), reducing visual quality and overall dissatisfaction...

The global consensus TFOS DEWS II dry eye diagnostic test battery was developed to help provide guidance on the key outcome measures for the diagnosis...

Having embraced the decision to arrange sales meetings for as many of its key customers as possible, the family-owned, Italian frames company De Rigo was...